A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

NCT02912494 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: JR-131
DRUG: Darbepoetin alfa

Sponsor

Kissei Pharmaceutical Co., Ltd.

Collaborators

[object Object]